eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
1/2010
vol. 5
 
Share:
Send email
Share:
abstract:
Case report

Evaluation of the treatment efficacy with adalimumab in Crohn’s disease – case report

Piotr Eder
,
Liliana Łykowska-Szuber
,
Iwona Krela-Kazimierczak
,
Katarzyna Iwanik
,
Katarzyna Karmelita-Katulska
,
Przemysław Majewski
,
Krzysztof Linke

Przegląd Gastroenterologiczny 2010; 5 (1): 47–51
DOI: https://doi.org/10.5114/pg.2010.13947
Online publish date: 2010/05/07
View full text Get citation
 
PlumX metrics:
Usage of anti-TNF-α agents in Crohn’s disease is one of the most important therapeutic achievements in Gastro-enterology over the last few years. Unfortunately there is still a lack of evidence on how to assess objectively the performance of this biological therapy. In this paper we present a case study of a patient treated with adalimumab, in which we assessed the efficacy of the treatment relying not only on the clinical indices and laboratory markers, but also on endoscopic, histological, and radiological methods.
keywords:

Crohn’s disease, adalimumab, mucosal healing
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.